These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27354458)

  • 1. Use of Performance-Enhancing Substances.
    LaBotz M; Griesemer BA;
    Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27354458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance-enhancing substances in sports: a review of the literature.
    Momaya A; Fawal M; Estes R
    Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Popular ergogenic drugs and supplements in young athletes.
    Calfee R; Fadale P
    Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood.
    Dodge TL; Jaccard JJ
    J Adolesc Health; 2006 Sep; 39(3):367-73. PubMed ID: 16919798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional supplements and ergogenic AIDS.
    Liddle DG; Connor DJ
    Prim Care; 2013 Jun; 40(2):487-505. PubMed ID: 23668655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Youth resistance training: updated position statement paper from the national strength and conditioning association.
    Faigenbaum AD; Kraemer WJ; Blimkie CJ; Jeffreys I; Micheli LJ; Nitka M; Rowland TW
    J Strength Cond Res; 2009 Aug; 23(5 Suppl):S60-79. PubMed ID: 19620931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():30-43. PubMed ID: 26881771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-Based Supplements for the Enhancement of Athletic Performance.
    Peeling P; Binnie MJ; Goods PSR; Sim M; Burke LM
    Int J Sport Nutr Exerc Metab; 2018 Mar; 28(2):178-187. PubMed ID: 29465269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adverse health consequences of the use of multiple performance-enhancing substances--a deadly cocktail.
    Perera NJ; Steinbeck KS; Shackel N
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4613-8. PubMed ID: 24217902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Legal Performance-Enhancing Substances and Use of Anabolic-Androgenic Steroids in Young Adults.
    Nagata JM; Ganson KT; Gorrell S; Mitchison D; Murray SB
    JAMA Pediatr; 2020 Oct; 174(10):992-993. PubMed ID: 32421175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance-enhancing drug use in young athletes.
    Laos C; Metzl JD
    Adolesc Med Clin; 2006 Oct; 17(3):719-31; abstract xii. PubMed ID: 17030288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance-Enhancing Substances.
    Chorley JN; Anding RH
    Adolesc Med State Art Rev; 2015 Apr; 26(1):174-88. PubMed ID: 26514038
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of Parent-Adolescent Communication About Anabolic Steroids on Adolescent Athletes' Willingness to Try Performance-Enhancing Substances.
    Dodge T; Clarke P
    Subst Use Misuse; 2015; 50(10):1307-15. PubMed ID: 25629954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012-2017: implications for policy and regulatory change.
    Bonny-Noach H; Berkovitz R; Shapira B
    Isr J Health Policy Res; 2020 May; 9(1):14. PubMed ID: 32362275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances.
    Cadwallader AB; Murray B
    Int J Sport Nutr Exerc Metab; 2015 Aug; 25(4):396-404. PubMed ID: 25675030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans.
    Isenmann E; Ambrosio G; Joseph JF; Mazzarino M; de la Torre X; Zimmer P; Kazlauskas R; Goebel C; Botrè F; Diel P; Parr MK
    Arch Toxicol; 2019 Jul; 93(7):1807-1816. PubMed ID: 31123801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the use of effective ergogenic aids among professional athletes.
    Frączek B; Warzecha M; Tyrała F; Pięta A
    Rocz Panstw Zakl Hig; 2016; 67(3):271-8. PubMed ID: 27546324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IOC Consensus Statement: Dietary Supplements and the High-Performance Athlete.
    Maughan RJ; Burke LM; Dvorak J; Larson-Meyer DE; Peeling P; Phillips SM; Rawson ES; Walsh NP; Garthe I; Geyer H; Meeusen R; van Loon L; Shirreffs SM; Spriet LL; Stuart M; Vernec A; Currell K; Ali VM; Budgett RGM; Ljungqvist A; Mountjoy M; Pitsiladis Y; Soligard T; Erdener U; Engebretsen L
    Int J Sport Nutr Exerc Metab; 2018 Mar; 28(2):104-125. PubMed ID: 29589768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent performance enhancing substance use: regional differences across the US.
    Thorlton JR; McElmurry B; Park C; Hughes T
    J Addict Nurs; 2012 May; 23(2):97-111. PubMed ID: 22494182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of use of performance-enhancing substances among United States adolescents.
    Castillo EM; Comstock RD
    Pediatr Clin North Am; 2007 Aug; 54(4):663-75, ix-x. PubMed ID: 17723869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.